Under this new arrangement, Volta Medical's AI software will be integrated into GE Healthcare offerings to improve AFib outcomes. 

While 16% of male cardiologists have a net worth of more than $5 million, the same is true for just 6% of female cardiologists.

Physicians and researchers complete thousands of clinical trials each year, but some findings prove far more significant than others. For cardiologist Dharmesh Patel, MD, the results of the SMART trial have changed the way he’s managing and recommending treatment for women with symptomatic severe aortic stenosis.

Magenta Medical plans to use some of the new financing to secure FDA approval for its Elevate LVAD. Novo Holdings, the controlling shareholder of international healthcare company Novo Nordisk, led the funding round.

Some of the most talked about data at ACC.24 were the results of a late-breaking clinical trial comparing different transcatheter aortic valve replacement (TAVR) valves in patients with a small aortic annulus. 

The young patient was discharged 10 days later, and no postoperative complications have been reported.

Restore Medical's ContraBand system was designed to address symptoms in HFrEF patients who do not respond to other therapies. 

Trainees interested in interventional cardiology will now be able to use the Match program to find the right program for their needs. The move is associated with multiple benefits as well as some key challenges.

Abandoned metal wire leads for pacemakers and ICDs did not present a serious safety issue in a study of 80 patients, but a handful of patients did experience a significant change in the composite of capture threshold, sensing or lead impedance.

Medicare rescinded the provision in the 2024 Medicare Physician Fee Schedule, but the law remains on the books.